More on RGNX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.03 |
|
|||
| Open | $8.24 | ||||
| 52 Wk High | $25.00 | ||||
| 52 Wk Low | $7.07 | ||||
| Day High | $8.31 | ||||
| Day Low | $7.76 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,115,691 | ||||
- Form 4 REGENXBIO Inc. For: Aug 25 Filed by: Ciongoli Gregory Austin
- Form 3 REGENXBIO Inc. For: Aug 25 Filed by: Ciongoli Gregory Austin
- Regenxbio Inc. (RGNX) PT Lowered to $21 at H.C. Wainwright
- Form 8-K REGENXBIO Inc. For: Aug 25
- RegenxBio adds new board member as two directors retire
- REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli
- Regenxbio Inc. (RGNX) PT Lowered to $29 at Baird
- Form 8-K REGENXBIO Inc. For: Aug 24
- Regenxbio (RGNX) to Resume Trading at 7:25 am ET
- FDA places clinical hold on Regenxbio's RGX-121 gene therapy for Hunter Syndrome
Entities mentioned with RGNX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13G | View Related Stories »
- Show More...
